Siemens Healthineers Focuses on Procedural Imaging as BMV MEDTECH Expands Its General Ultrasound Line

On October 12, 2026, Siemens Healthineers announced a shift in its ultrasound strategy: it stopped selling general imaging ultrasound systems, including the ACUSON Sequoia, Redwood, Juniper and Maple, to focus its ultrasound business on procedural imaging and image-guided therapy. The move highlights a strategic split in the global ultrasound market. While one diversified company is scaling back general imaging, the market continues to grow, and GE HealthCare, Philips and Fujifilm are still launching new systems. Manufacturers such as BMV MEDTECH are also expanding general ultrasound lines that cover cart-based, portable and wireless handheld systems, and offering OEM/ODM and distribution partnerships to customers worldwide.

Siemens Healthineers refocuses ultrasound on procedural imaging

According to the company’s official announcement, as of October 12, 2026 it no longer sells general imaging ultrasound systems, including the ACUSON Sequoia, Redwood, Juniper and Maple. It continues to offer procedural ultrasound systems: the ACUSON Origin cardiovascular platform, the P500 intracardiac echocardiography (ICE) system, and the Freestyle portable intraoperative ultrasound, along with dedicated software and catheters.

Company leaders note that medicine is evolving, and imaging is increasingly becoming part of treatment rather than diagnosis alone. The decision reflects both the long-term growth and differentiation the company sees in procedural imaging, and the intense competition and margin pressure in general imaging.

Fairly described, this is a refocusing rather than an exit from ultrasound — Siemens Healthineers continues to invest in procedural ultrasound and image-guided therapy.

The general ultrasound market remains large, and leading vendors keep investing

Market research firms such as Global Growth Insights and Fortune Business Insights put the global ultrasound market at roughly USD 8 to 11 billion in 2025, with figures varying by methodology, and most expect growth over the coming years. General imaging ultrasound covers a wide range of routine examinations — abdomen, thyroid, soft tissue, urology and musculoskeletal — forming a sizeable, high-frequency segment.

Around 2026, leading vendors continued to invest in general ultrasound:

• GE HealthCare — new LOGIQ general ultrasound systems and an expanded LOGIQ e portable line, covering musculoskeletal, emergency, critical care and anesthesia.
• Philips — the Alturion system, aimed at high-volume clinical settings.
• Fujifilm Healthcare — ARIETTA platforms with upgraded high-end imaging and intelligent features.

There is no collective withdrawal from general imaging; it remains competitive but still a priority for leading global companies.

BMV MEDTECH expands its general ultrasound line

While some companies scale back, BMV MEDTECH continues to expand its general ultrasound line in several forms:

• Premium cart-based and portable color Doppler systems (BMV imaging) — whole-body imaging of the abdomen, cardiovascular system, obstetrics and gynecology, and musculoskeletal system, with flexible configurations for hospitals and primary care.
• Wireless handheld ultrasound (SonoMaxx MX series) — a three-in-one pocket probe combining linear, convex and phased-array transducers; supports iOS, Android and Windows and fits in a pocket for bedside, emergency, anesthesia guidance and critical care.

The company develops core components — transducers, main units and boards — in-house, and focuses on image quality and AI-assisted measurement to improve examination efficiency. For BMV MEDTECH, ultrasound not only completes the imaging portfolio, but also extends the business from large imaging equipment into more clinical departments, including the abdomen, cardiovascular system, obstetrics, emergency and critical care, where frequent exams and flexible configurations open new opportunities.